Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) develops proprietary cell therapies for the treatment of cancer and degenerative diseases. We conduct immuno-oncology and stem cell clinical trials in China using products from our integrated GMP laboratory. Our GMP facilities in China, consisting of twelve independent cell production lines, are designed and managed according to both China and U.S. GMP standards. For more information, please visit www.cellbiomedgroup.com.

Sailing Capital

Wuhan Dangdai Science & Technology Industries Group

YF Capital

TF Capital

Sequoia Capital China

AstraZeneca

Celllular Biomedicine Group

Eureka Therapeutics is a biopharmaceutical company focused on developing novel T-cell therapies for the treatment of solid tumors.

Eureka Therapeutics

Kite Pharma is a biopharmaceutical company specializing in the development of cancer immunotherapy products.

Kite Pharma

Iovance is a biotechnology company dedicated to the development and commercialization of novel cancer immunotherapies.

Iovance

AIVITA Biomedical is a company specializing in the development of stem cell-based therapies for regenerative medicine.

AIVITA Biomedical

Accellta is a manufacturer of human Trophoblast Stem Cells (hTSCs) and hTSC-derived iPSCs for regenerative medicine, with a focus on mass production of stem cells in 3D bioreactors.

Accellta

Cellular Biomedicine Group, Inc. develops proprietary cell therapies for the treatment of cancer and degenerative diseases. The company conducts immuno-oncology and stem cell clinical trials in China using products from its integrated GMP laboratory.

Cellular Biomedicine Group, Inc.

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general	Mar 4, 2024 9:59 PM	030d7f6a
public peers	general
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Mar 4, 2024 9:59 PM	e146b396
company summary	general
signals	general
crunchbase trigger	general	Nov 4, 2024 10:53 AM	04bb1713
crunchbase profile	general
li profile	general	Mar 4, 2024 9:59 PM	283fe8b3
translate crunchbase fundingrounds	general
peers	general
news basic	general	Mar 4, 2024 9:59 PM	577a976a
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:CELLBIOMEDGROUP

Cellular Biomedicine Group, Inc.